These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 17684611

  • 21. Potential therapeutic role for statins in respiratory disease.
    Hothersall E, McSharry C, Thomson NC.
    Thorax; 2006 Aug; 61(8):729-34. PubMed ID: 16877692
    [Abstract] [Full Text] [Related]

  • 22. [Do the pleiotropic effects of statins have a clinical significance?].
    Vergès B.
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1231-5. PubMed ID: 15669365
    [Abstract] [Full Text] [Related]

  • 23. Statin therapy-evidence beyond lipid lowering contributing to plaque stability.
    de Lorenzo F, Feher M, Martin J, Collot-Teixeira S, Dotsenko O, McGregor JL.
    Curr Med Chem; 2006 Dec; 13(28):3385-93. PubMed ID: 17168712
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Usefulness of statins in protecting against ventricular arrhythmias.
    Abinader EG.
    Am J Cardiol; 2006 Jan 01; 97(1):153-4. PubMed ID: 16377305
    [No Abstract] [Full Text] [Related]

  • 27. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.
    Jain MK, Ridker PM.
    Nat Rev Drug Discov; 2005 Dec 01; 4(12):977-87. PubMed ID: 16341063
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
    Albert MA, Danielson E, Rifai N, Ridker PM, PRINCE Investigators.
    JAMA; 2001 Jul 04; 286(1):64-70. PubMed ID: 11434828
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L, Uzick M.
    Altern Med Rev; 2001 Jun 04; 6(3):248-71. PubMed ID: 11410071
    [Abstract] [Full Text] [Related]

  • 36. Statins: potential new indications in inflammatory conditions.
    Endres M.
    Atheroscler Suppl; 2006 Apr 04; 7(1):31-5. PubMed ID: 16503422
    [Abstract] [Full Text] [Related]

  • 37. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
    Shimizu K, Aikawa M, Takayama K, Libby P, Mitchell RN.
    Circulation; 2003 Oct 28; 108(17):2113-20. PubMed ID: 14517172
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.